Ultrasound-guided anterior Quadratus Lumborum Block for postoperative pain after laparoscopic bariatric surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202305838359772

Enrollment

Registered

2023-05-18

Start date

2023-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Nutritional, Metabolic, Endocrine

Interventions

Quadratus lumborum block

placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: laparoscopic bariatric surgery (laparoscopic sleeve gastrectomy or gastric bypass) ASA III BMI = 35 kg/m2 with comorbidity or = 40 kg/m2 without comorbidity

Exclusion criteria

Exclusion criteria: patients diagnosed with obstructive sleep apnea Pickwickian syndrome, coagulation defects hypersensitivity to bupivacaine contraindication to the use of NSAIDS sepsis at the site of injection or conversion to laparotomy.

Design outcomes

Primary

Measure	Time frame
intra- and postoperative pain control and opioid requirements in laparoscopic bariatric procedures.	—

Secondary

Measure	Time frame
side effects such as nausea and decreased bowel motility.	—

Countries

Egypt

Contacts

Public Contactehsan deghidy

lecturer of Biomedical Informatics and Medical Statistics

drehsan.deghidy@yahoo.com00201063199658

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026